| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/18/2012 | EP2407157A1 Lipid bilayer carrier for drugs or imaging agents |
| 01/18/2012 | EP2406302A1 Multifunctional contrast agent using biocompatible polymer and preparation method |
| 01/18/2012 | EP2405904A2 Method of treating eczema |
| 01/18/2012 | EP1668120B1 Method for detecting cancer cells and monitoring cancer therapy |
| 01/18/2012 | EP1659858B1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/18/2012 | EP1123388B1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 01/18/2012 | CN102325551A Fluorescent probes |
| 01/18/2012 | CN102321600A Modified beta-secretase and application thereof |
| 01/18/2012 | CN102321242A Polyethylene glycol-polylactic acid-poly-L-lysine copolymer, preparation method thereof and application thereof as gene or drug vector |
| 01/18/2012 | CN102319443A Low-field high-relaxation rate magnetic resonance imaging (MRI) contrast agent and preparation method and application thereof |
| 01/18/2012 | CN102319442A Preparation method of core-shell type nanoparticle |
| 01/18/2012 | CN102126986B Triiodobenzene compound and contrast medium with same |
| 01/17/2012 | US8097615 Neurofibrillary labels |
| 01/17/2012 | US8097468 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies |
| 01/17/2012 | US8097283 Methods and compositions for imaging |
| 01/17/2012 | US8097282 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness |
| 01/17/2012 | US8097252 Methods and compositions for administering therapeutic and diagnostic agents |
| 01/17/2012 | US8097239 use of a polyhydroxy component for increasing the solubility of a bioactive compound, especially a peptide in a lipid-based controlled-release matrix; bioadhesive |
| 01/17/2012 | CA2583009C Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 01/17/2012 | CA2504313C Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 01/17/2012 | CA2504269C Piperazinyl and diazapanyl benzamides and benzthioamides |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2402117C Chimeric animal model susceptible to human hepatitis c virus infection |
| 01/12/2012 | WO2012006038A2 Agents and compounds for imaging and other applications, and methods of use and synthesis thereof |
| 01/12/2012 | WO2012004322A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011110347A3 Compositions for colon lavage and methods of making and using same |
| 01/12/2012 | WO2011109832A3 Methods and compositions for nmr spectroscopic analysis using isotopic labeling schemes |
| 01/12/2012 | WO2011109216A3 Nir materials and nanomaterials for theranostic applications |
| 01/12/2012 | WO2011095836A3 Trackable therapeutic macrophages |
| 01/12/2012 | US20120009126 Optical determination of glucose utilizing boronic acid adducts |
| 01/12/2012 | US20120009125 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | US20120009123 Albumin binding peptide-mediated disease targeting |
| 01/12/2012 | US20120009121 Psma-targeting compounds and uses thereof |
| 01/12/2012 | DE102010027016A1 New steroid-styryl dye conjugates useful e.g. for simulation and direct light optical detection of the behavior of steroid in the living biological tissue in the presence of a steroid binding protein |
| 01/12/2012 | CA2804327A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/11/2012 | EP2404899A1 Contrast medium for thrombus detection |
| 01/11/2012 | EP2404619A1 Injectable composition composed of an injectable medication and a gel |
| 01/11/2012 | EP2404500A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/11/2012 | EP1562638B1 Lymph node contrast agent |
| 01/11/2012 | EP1191947B1 Methods for treating avm' using radioactive compositions |
| 01/11/2012 | CN102316903A PDGF-RBeta BINDERS |
| 01/11/2012 | CN102316902A Glutathione-based drug delivery system |
| 01/11/2012 | CN102311454A Compound lipid containing porphyrin ring functional groups, intermediate, preparation method and application thereof |
| 01/11/2012 | CN101830901B Selenite ion type compound and preparation method and application thereof |
| 01/10/2012 | US8092782 Polybiotin compounds of magnetic resonance imaging and drug delivery |
| 01/10/2012 | US8092781 Treatment of sinusitis in mammals with clostridia neurotoxins |
| 01/10/2012 | US8092779 Post-biopsy cavity treatment implants and methods |
| 01/10/2012 | US8092390 Medico-surgical devices |
| 01/10/2012 | CA2592754C Method for the preparation of micro-porous crystals and conjugates thereof |
| 01/10/2012 | CA2522308C Radioactively marked microparticles, method for the production thereof and use of the same |
| 01/05/2012 | WO2012003478A2 Detecting targets using mass tags and mass spectrometry |
| 01/05/2012 | WO2012003334A2 Molecular probes for imaging of myelin |
| 01/05/2012 | WO2012002760A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 01/05/2012 | WO2012002759A2 Microvesicles derived from cell protoplast, and use thereof |
| 01/05/2012 | WO2012002388A1 Drug delivery agent to sentinel lymph node |
| 01/05/2012 | WO2012002387A1 Sentinel lymph node visualizing agent |
| 01/05/2012 | WO2012001579A1 Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (mpi) |
| 01/05/2012 | WO2012001578A1 Single-step synthesis of iron oxide nanoparticles |
| 01/05/2012 | WO2012001009A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | WO2011143360A8 Compositions, methods and systems for the synthesis and use of imaging agents |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120005766 Methods of identifying agents that modulate phenotypes related to disruptions, of a gene encoding PRO235 polypeptide |
| 01/05/2012 | US20120005765 Animal model for parkinson's disease |
| 01/05/2012 | US20120004531 Innately Multimodal Nanoparticles |
| 01/05/2012 | US20120004530 Quantification of intracellular and extracellular spio agents with r2 and r2* mapping |
| 01/05/2012 | US20120003160 Macrophage-Enhanced MRI (MEMRI) in a Single Imaging Session |
| 01/05/2012 | US20120003159 Compositions and methods for enhancing contrast in imaging |
| 01/05/2012 | US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same |
| 01/05/2012 | US20120003157 Use of anti-90k monoclonal antibodies for the prevention and treatment of tumors and metastases thereof |
| 01/05/2012 | US20120003156 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/05/2012 | US20120003155 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120003152 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 01/05/2012 | US20120003151 Method for early imaging of atherosclerosis |
| 01/05/2012 | CA2802816A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/04/2012 | EP2402449A2 An animal model and a method for producing an animal model |
| 01/04/2012 | EP2402008A1 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 01/04/2012 | EP2400990A2 In situ methods for monitoring the emt status of tumor cells in vivo |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102304179A GLP-1 and exendin related invention |
| 01/04/2012 | CN102028960B New application of normal saline injection in preparation of diagnosticum |
| 01/04/2012 | CN101862461B Gadolinium-containing macromolecular contrast agent for specific imaging of lymphatic system and preparation method thereof |
| 01/04/2012 | CN101433515B High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 01/03/2012 | US8088968 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation |
| 01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 01/03/2012 | US8088579 Complement factor H for diagnosis of age-related macular degeneration |
| 01/03/2012 | US8088408 Method and composition for delivery of medicants to animals |
| 01/03/2012 | US8088361 Treatment of allergic rhinitis in mammals with Clostridia neurotoxins |
| 01/03/2012 | US8088360 Treatment of infectious rhinitis in mammals with clostridia neurotoxins |
| 01/03/2012 | US8088359 Means and methods of using a NADPH oxidase inhibitor for the treatment of hearing loss and phantom hearing |
| 01/03/2012 | US8088358 Salt formation; high pressure heating and mixing of anionic and cationic solutions; stirring, autoclaving, precipitation, neutralization, separating, centrifuging; nuclear magnetic resonance intensifiers; contrast agents |
| 01/03/2012 | CA2579619C Radio-opaque polymeric biomaterials |
| 01/03/2012 | CA2491216C Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/03/2012 | CA2484869C Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations |
| 01/03/2012 | CA2399293C Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 12/29/2011 | WO2011163136A2 Tuned multifunctional magnetic nanoparticles for biomedicine |
| 12/29/2011 | WO2011162904A2 Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement |
| 12/29/2011 | WO2011160216A2 Compounds useful in imaging and therapy |